Commercial Strategy & Market Access

Growth through innovation is often a top priority, but ensuring that the process delivers competitive advantage is challenging. The demands of value-based healthcare put even more pressure on innovation as stakeholders demand increased quality while controlling costs. Meeting this challenge requires identifying real clinical and economic unmet needs and the types of evidence that will be required to support adoption and reimbursement. We focus on value assessment and creation that helps companies achieve sustained competitive advantage.

It’s one thing to identify a market opportunity, but another to execute and win in today’s marketplace. We embed our product development and market access expertise into market opportunity assessment and forecasting. We understand that payer acceptance, health economic value, and evidence investment requirements are the building blocks for robust business cases. Our proprietary analytics enable us to deliver real-world insights that inform actionable market and growth strategies.

Payers and health systems are demanding more from novel drugs, devices, and diagnostic technologies than ever before. We have a deep understanding of the global payer landscape including financial risks at hospitals and within healthcare systems to better align the value our clients deliver with the expectations of reimbursement and funding stakeholders. We excel at building strategic reimbursement roadmaps that address everything from coding, to policy, pricing, and evidence development.

Payers, clinicians, regulators, and investors are increasingly assessing the value of innovation in terms of results ­—both clinical and economic. We develop robust health economic analysis and use communication tools that deliver success in an environment where proving clinical and economic value to payers and providers is essential for success.

Today’s medical technology M&A (Mergers and Acquisitions) environment is extremely competitive. Innovators must move quickly to identify opportunities, evaluate them, and close transactions that will drive real growth. We help clients anticipate market changes to create sustained value and gain an edge over the competition. Our expertise is built on the realities of payer coverage and pricing in a value-based healthcare environment. We identify and prioritize opportunities, offering you a much clearer picture of transaction opportunities and risks.

Delivering the right treatment to the right patient at the right time depends on a complex mix of analytics and insights. Our capabilities in global market access, commercial strategy, and data and advanced analytics puts us in a unique position to support medicine innovators in developing effective commercialization strategies and globally scalable solutions needed to drive routine patient access to appropriate diagnostic technologies and resulting intervention.